Teikyo University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Tokyo Japan (1931)

Organization Overview

First Clinical Trial
2006
NCT00379015
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Division of Cardiology, Dpt of Medicine, Teikyo University | Teikyo University , Department Surgery | Teikyo University Hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Angina Pectoris (Phase 3)

Angina, Stable (Phase 3)

Breast Neoplasms (Phase 2)

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 4)

Esophageal Neoplasms (Phase 1)

Fructose Intolerance (Phase 2)

Hypertension (Phase 2)

Infarction (Phase 3)

Kidney Diseases (Phase 2)

Myocardial Infarction (Phase 3)

Myocardial Ischemia (Phase 4)

Polycystic Kidney, Autosomal Dominant (Phase 2)

Polycystic Kidney Diseases (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 16